High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt;Prévalence élevée de la résistance de Klebsiella pneumoniae médiée par les carbapénèmases dans des isolats de K. pneumoniae en Égypte

Eastern Mediterranean Health Journal

Volumn 19, Issue 11, 2013, Pages 947-952

  Metwally, L ^a   Gomaa, N ^a   Attallah, M ^b   Kamel, N ^c  

^a SUEZ CANAL UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL DNA; CARBAPENEM; CARBAPENEMASE; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULFADOXINE PLUS TRIMETHOPRIM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BLA KPC GENE; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; CONTROLLED STUDY; DNA EXTRACTION; EGYPT; GENE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; EGYPT; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PROSPECTIVE STUDIES;

EID: 84890471733     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.11.947     Document Type: Article

References (29)

1. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infectious Diseases, 2009, 9:228-236.
2. Arnold RS et al. Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. Southern Medical Journal, 2011, 104:40-45.
3. Yigit H et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 2001, 45:1151-1161.
4. Hirsch EB et al. Emergence of KPC-producing Klebsiella pneumoniae in Texas. Diagnostic Microbiology and Infectious Disease, 2011, 69:234-235.
5. Centers for Disease Control and Prevention (CDC). Carbapenem-resistant Klebsiella pneumoniae associated with a longterm-care facility-West Virginia, 2009-2011. Morbidity and Mortality Weekly Report, 2011, 60:1418-1420.
6. Bratu S et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York city: a new threat to our antibiotic armamentarium. Archives of Internal Medicine, 2005, 165:1430-1435.
7. Brandon Kitchel et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrobial Agents and Chemotherapy, 2009, 53:3365-3370.
8. Steinmann J et al. Outbreak due to a Klebsiella pneumonia strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Eurosurveillance, 2011, 16:19944.
9. Chung KP et al. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. Journal of Antimicrobial Chemotherapy, 2011, 66:1182-1184.
10. Beirao EM et al. Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil. Brazilian Journal of Infectious Diseases, 2011, 15:69-73.
11. Gomez-Gil M R et al. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. Journal of Antimicrobial Chemotherapy, 2010, 65:2695-2697.
12. Leavitt A et al. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrobial Agents and Chemotherapy, 2010, 54:3002-3006.
13. Souli M et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clinical Infectious Diseases, 2010, 50:364-373.
14. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI document M100-S19. Wayne, Pennsylvania, Clinical and Laboratory Standards Institute, 2009.
15. Performance standards for antimicrobial susceptibility testing, 20th informational supplement: M100-S20 & M100-S-20-U. Wayne, Pennsylvania, Clinical and Laboratory Standards Institute, 2010.
16. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. M100-S22. Wayne, Pennsylvania, Clinical and Laboratory Standards Institute, 2012.
17. Endimiani A et al. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrobial Agents and Chemotherapy, 2008, 52:2680-2682.
18. Neuner EA et al. Treatment and outcomes in carbapenemresistant Klebsiella pneumoniae bloodstream infections. Diagnostic Microbiology and Infectious Disease, 2011, 69:357-362.
19. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. International Journal of Medical Microbiology, 2010, 300:371-379.
20. Doumith M et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. Journal of Antimicrobial Chemotherapy, 2009, 63:659-667.
21. Cuzon G et al. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. International Journal of Antimicrobial Agents, 2010, 35:265-268.
22. Raghunathan A, Samuel L, Tibbetts RJ. Evaluation of a real-time PCR assay for the detection of the Klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified Hodge test. American Journal of Clinical Pathology, 2011, 135:566-571
23. Hindiyeh M et al. Rapid detection of blaKPC carbapenemase genes by internally controlled real-time PCR assay using Bactec blood culture bottles. Journal of Clinical Microbiology, 2011, 49(7):2480-2484.
24. Doern CD, Dunne WM Jr, Burnham CA. Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods. Journal of Clinical Microbiology, 2011, 49:1143-1147.
25. Carvalhaes CG et al. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. Journal of Antimicrobial Chemotherapy, 2010, 65:249-251.
26. Landman D et al. Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints. Journal of Clinical Microbiology, 2011, 49:3931-3933.
27. Endimiani A et al. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. Journal of Clinical Microbiology, 2010, 48:4417-4425.
28. Hu F et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. Journal of Medical Microbiology, 2012, 61:132-136.
29. Schechner V et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. Journal of Clinical Microbiology, 2009, 47:3261-3265.